Search results

Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.

We're playing a leading role in the AI and digital regulations service which supports the development and adoption of AI and data-driven technologies in health and care.

Tell us about an interventional procedure you think should be assessed by NICE.

Home What NICE does NICE International {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1

If you’re unsure where to start or your circumstances are unique, we encourage you to get in touch. We’ll work with you to unpick your challenges and find a solution that meets your needs.

The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.

A step-by-step timeline of the process we used to develop single technology appraisals (STA).

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

Our forward view highlights the topics we will prioritise in the coming year.

NICE's decisions on how we prioritise topics, by year.

Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

Each year we work with NHSE and the DHSC to prioritise topics for development.

Our centralised approach to prioritising guidance topics ensures that we produce guidance that is relevant, timely, accessible, and has demonstrable impact.

Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

Read biographies for all members of NICE's indicator advisory committee.